Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026)

Evolus (EOLS) reported Amortization of Deferred Charges of $361000.0 for Q1 2026, up 19.93% on a YoY basis from $301000.0 in Q1 2025, and up 5.25% quarter-over-quarter from $343000.0 in Q4 2025.

Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends

Evolus has reported Amortization of Deferred Charges for 9 years, with the latest figure at $361000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortization of Deferred Charges rose 19.93% year-over-year to $361000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 15.2% YoY), and the FY2025 full-year result was $1.3 million, up 12.38% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $361000.0, up from $343000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $361000.0 in Q1 2026, with the low at $263000.0 in Q1 2022.
  • Historically, Amortization of Deferred Charges has averaged $294058.8 across 5 years, with a median of $282000.0 in 2024.
  • The largest YoY upside for Amortization of Deferred Charges was 188.31% in 2022 against a maximum downside of 58.0% in 2022.
  • Evolus' Amortization of Deferred Charges stood at $281000.0 in 2022, then fell by 2.85% to $273000.0 in 2023, then advanced by 9.16% to $298000.0 in 2024, then gained by 15.1% to $343000.0 in 2025, then climbed by 5.25% to $361000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $361000.0 (Q1 2026), $343000.0 (Q4 2025), and $336000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 361,000.00
Mar 31, 2026 361,000.00
Dec 31, 2025 343,000.00
Dec 31, 2025 343,000.00
Sep 30, 2025 336,000.00
Sep 30, 2025 336,000.00
Jun 30, 2025 309,000.00
Jun 30, 2025 309,000.00
Mar 31, 2025 301,000.00
Mar 31, 2025 301,000.00
Dec 31, 2024 298,000.00
Dec 31, 2024 298,000.00
Sep 30, 2024 290,000.00
Sep 30, 2024 290,000.00
Jun 30, 2024 282,000.00
Jun 30, 2024 282,000.00
Mar 31, 2024 277,000.00
Mar 31, 2024 277,000.00
Dec 31, 2023 273,000.00
Dec 31, 2023 273,000.00